InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Henn Matthew R.. Officer active across 1 company, notably Seres Therapeutics, Inc.. Cumulatively, 14 reports have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €318. History available since 5 July 2022. The latest transaction was filed on 17 August 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations
Henn Matthew R. is a declarant linked to Seres Therapeutics, Inc. (XNAS), with 12 filings in total. In the sampled recent filings, the period runs from 2022-07-06 to 2026-02-18, the modal transaction nature is option exercise, and the only amount shown in the top filings is EUR 146231.8462930751 on 2022-07-06.